title: Immunity to adult cestodes: basic knowledge and vaccination problems. A review.
abstract: Immunity in mammals to intestinal cestodes has been reviewed using the normal final host infected with the tapeworms Hymenolepis diminuta in rats and H. microstoma and H. nana in mice as a model. Primary infections up to a certain level continue to live as long the host, while most worms in infections with larger doses are destrobilated and expelled. It has been argued that concomitant immunity against a superimposed infection exists in rats and mice infected with H. diminuta and H. microstoma, respectively, and suggested that it also takes place in humans infected with Taenia spp. Immunity to secondary infections after expulsion of a primary infection occurs, but immunological memory is rather short-lived, although depression of worm growth occurs for at least two third of the rat's life. Serum antibodies have been shown to produce a direct precipitate on the surface of cestodes in vitro, but a direct effect of antibodies in vivo or the relationship with e.g. host effector cells, like mast cells and eosinophils, is unknown. It has been shown that peritoneal exudate cells from rats are able to kill H. diminuta in vitro. Very little is known about the mechanisms of tapeworms to counteract host immunological responses, but the tegumental glycoconjugates and discoidal secretory bodies are possible candidates. Passive transfer of immunity by mesenteric lymph node cells has only been successful using cells from H. nana egg-infected mice and has shown that only short-lived proliferating cells are responsible for transferring immunity. Vaccination procedures and problems are discussed with special reference to E. granulosus in dogs.
authors.affiliation: Department of Parasitology, University of Copenhagen, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Andreassen
mesh_terms: D000818:Animals; D000909:Antibodies, Helminth / Q000276:immunology; D002590:Cestode Infections / Q000276:immunology / Q000517:prevention & control; D006224:Cricetinae; D006790:Host-Parasite Interactions; D006801:Humans; D006925:Hymenolepiasis / Q000276:immunology* / Q000517:prevention & control; D006926:Hymenolepis / Q000145:classification / Q000254:growth & development / Q000276:immunology*; D016867:Immunocompromised Host; D007156:Immunologic Memory; D016219:Immunotherapy, Adoptive; D007411:Intestinal Diseases, Parasitic / Q000276:immunology* / Q000517:prevention & control; D051379:Mice; D051381:Rats; D013045:Species Specificity; D014611:Vaccination
chemical_list: D000909:Antibodies, Helminth